The equities market and stock exchange traded funds ended November in listless trading after hitting record highs before Thanksgiving.

The Dow Jones Industrial Average gained 3.7% over November. Meanwhile, the Nasdaq Composite rose 2.7% and the S&P 500 increased 3.0%.

Both the S&P 500 and the Dow ended at a new all-time high in the last week of November. On Nov. 27, the S&P 500 finished at 1,807.23 and the Dow closed at 16,097.33. However, both indices were slightly down on the last day of trading for the month.

The top non-leveraged ETFs over November include Global X China Financials ETF (NYSEArca: CHIX) up 11.2%, SPDR S&P Pharmaceuticals ETF (NYSEArca: XPH) up 10.5% and iShares China Large-Cap ETF (NYSEArca: FXI) up 10.0%.

Chinese stocks are rising to a one-month high after Beijing pledged extensive economic, legal and social reforms, reports Conrad de Aenlle for Reuters.

Pharmaceutical companies are posting better-than-expected growth year-over-year, with increased sales on more specialized drug products.

The worst performing non-leveraged funds for the month included SPECTRUM U.S. ETN (NYSEArca: EEH) down 45.0%, Global X Gold Explorers ETF (NYSEArca: GLDX) down 27.0% and Market Vectors Junior Gold Miners ETF (NYSEArca: GDXJ) dwon 23.6%.